NF2 and ependymoma: Sporadic NF2 mutations have been implicated in several cancers, including sporadic meningioma, ependymoma, and schwannoma, mesothelioma, breast cancer, hepatocellular carcinoma, prostate cancer, glioblastoma, thyroid cancer, melanoma, and renal cell carcinoma.